Risk factors associated with death due to severe fever with thrombocytopenia syndrome in hospitalized Korean patients (2018–2022)

Objectives Severe fever with thrombocytopenia syndrome (SFTS) has no vaccine or treatment and an extremely high fatality rate. We aimed to analyze and evaluate the risk factors for death associated with SFTS. Methods Among reports from 2018 to 2022, we compared and analyzed 1,034 inpatients aged 18...

Full description

Bibliographic Details
Main Authors: Jia Kim, Hyo-jeong Hong, Ji-hye Hwang, Na-Ri Shin, Kyungwon Hwang
Format: Article
Language:English
Published: Korea Disease Control and Prevention Agency 2023-06-01
Series:Osong Public Health and Research Perspectives
Subjects:
Online Access:http://ophrp.org/upload/pdf/j-phrp-2023-0048.pdf
_version_ 1797692889443074048
author Jia Kim
Hyo-jeong Hong
Ji-hye Hwang
Na-Ri Shin
Kyungwon Hwang
author_facet Jia Kim
Hyo-jeong Hong
Ji-hye Hwang
Na-Ri Shin
Kyungwon Hwang
author_sort Jia Kim
collection DOAJ
description Objectives Severe fever with thrombocytopenia syndrome (SFTS) has no vaccine or treatment and an extremely high fatality rate. We aimed to analyze and evaluate the risk factors for death associated with SFTS. Methods Among reports from 2018 to 2022, we compared and analyzed 1,034 inpatients aged 18 years or older with laboratory-confirmed SFTS who underwent complete epidemiological investigations. Results Most of the inpatients with SFTS were aged 50 years or older (average age, 67.6 years). The median time from symptom onset to death was 9 days, and the average case fatality rate was 18.5%. Risk factors for death included age of 70 years or older (odds ratio [OR], 4.82); agriculture-related occupation (OR, 2.01); underlying disease (OR, 7.20); delayed diagnosis (OR, 1.28 per day); decreased level of consciousness (OR, 5.53); fever/chills (OR, 20.52); prolonged activated partial thromboplastin time (OR, 4.19); and elevated levels of aspartate aminotransferase (OR, 2.91), blood urea nitrogen (OR, 2.62), and creatine (OR, 3.21). Conclusion The risk factors for death in patients with SFTS were old age; agriculture-related occupation; underlying disease; delayed clinical suspicion; fever/chills; decreased level of consciousness; and elevated activated partial thromboplastin time, aspartate aminotransferase, blood urea nitrogen, and creatine levels.
first_indexed 2024-03-12T02:34:05Z
format Article
id doaj.art-b014764fed824800ab7f3ce27fba5705
institution Directory Open Access Journal
issn 2233-6052
language English
last_indexed 2024-03-12T02:34:05Z
publishDate 2023-06-01
publisher Korea Disease Control and Prevention Agency
record_format Article
series Osong Public Health and Research Perspectives
spelling doaj.art-b014764fed824800ab7f3ce27fba57052023-09-05T01:42:51ZengKorea Disease Control and Prevention AgencyOsong Public Health and Research Perspectives2233-60522023-06-0114315116310.24171/j.phrp.2023.0048716Risk factors associated with death due to severe fever with thrombocytopenia syndrome in hospitalized Korean patients (2018–2022)Jia Kim0Hyo-jeong Hong1Ji-hye Hwang2Na-Ri Shin3Kyungwon Hwang4 Division of Zoonotic and Vector Borne Disease Control, Bureau of Infectious Disease Policy, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea Division of Zoonotic and Vector Borne Disease Control, Bureau of Infectious Disease Policy, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea Division of Zoonotic and Vector Borne Disease Control, Bureau of Infectious Disease Policy, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea Division of Zoonotic and Vector Borne Disease Control, Bureau of Infectious Disease Policy, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea Division of Zoonotic and Vector Borne Disease Control, Bureau of Infectious Disease Policy, Korea Disease Control and Prevention Agency, Cheongju, Republic of KoreaObjectives Severe fever with thrombocytopenia syndrome (SFTS) has no vaccine or treatment and an extremely high fatality rate. We aimed to analyze and evaluate the risk factors for death associated with SFTS. Methods Among reports from 2018 to 2022, we compared and analyzed 1,034 inpatients aged 18 years or older with laboratory-confirmed SFTS who underwent complete epidemiological investigations. Results Most of the inpatients with SFTS were aged 50 years or older (average age, 67.6 years). The median time from symptom onset to death was 9 days, and the average case fatality rate was 18.5%. Risk factors for death included age of 70 years or older (odds ratio [OR], 4.82); agriculture-related occupation (OR, 2.01); underlying disease (OR, 7.20); delayed diagnosis (OR, 1.28 per day); decreased level of consciousness (OR, 5.53); fever/chills (OR, 20.52); prolonged activated partial thromboplastin time (OR, 4.19); and elevated levels of aspartate aminotransferase (OR, 2.91), blood urea nitrogen (OR, 2.62), and creatine (OR, 3.21). Conclusion The risk factors for death in patients with SFTS were old age; agriculture-related occupation; underlying disease; delayed clinical suspicion; fever/chills; decreased level of consciousness; and elevated activated partial thromboplastin time, aspartate aminotransferase, blood urea nitrogen, and creatine levels.http://ophrp.org/upload/pdf/j-phrp-2023-0048.pdfepidemiological factorsrisk factorssevere fever with thrombocytopenia syndrome
spellingShingle Jia Kim
Hyo-jeong Hong
Ji-hye Hwang
Na-Ri Shin
Kyungwon Hwang
Risk factors associated with death due to severe fever with thrombocytopenia syndrome in hospitalized Korean patients (2018–2022)
Osong Public Health and Research Perspectives
epidemiological factors
risk factors
severe fever with thrombocytopenia syndrome
title Risk factors associated with death due to severe fever with thrombocytopenia syndrome in hospitalized Korean patients (2018–2022)
title_full Risk factors associated with death due to severe fever with thrombocytopenia syndrome in hospitalized Korean patients (2018–2022)
title_fullStr Risk factors associated with death due to severe fever with thrombocytopenia syndrome in hospitalized Korean patients (2018–2022)
title_full_unstemmed Risk factors associated with death due to severe fever with thrombocytopenia syndrome in hospitalized Korean patients (2018–2022)
title_short Risk factors associated with death due to severe fever with thrombocytopenia syndrome in hospitalized Korean patients (2018–2022)
title_sort risk factors associated with death due to severe fever with thrombocytopenia syndrome in hospitalized korean patients 2018 2022
topic epidemiological factors
risk factors
severe fever with thrombocytopenia syndrome
url http://ophrp.org/upload/pdf/j-phrp-2023-0048.pdf
work_keys_str_mv AT jiakim riskfactorsassociatedwithdeathduetoseverefeverwiththrombocytopeniasyndromeinhospitalizedkoreanpatients20182022
AT hyojeonghong riskfactorsassociatedwithdeathduetoseverefeverwiththrombocytopeniasyndromeinhospitalizedkoreanpatients20182022
AT jihyehwang riskfactorsassociatedwithdeathduetoseverefeverwiththrombocytopeniasyndromeinhospitalizedkoreanpatients20182022
AT narishin riskfactorsassociatedwithdeathduetoseverefeverwiththrombocytopeniasyndromeinhospitalizedkoreanpatients20182022
AT kyungwonhwang riskfactorsassociatedwithdeathduetoseverefeverwiththrombocytopeniasyndromeinhospitalizedkoreanpatients20182022